Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression
暂无分享,去创建一个
G. Van den Berghe | G. V. Berghe | T. Roskams | A. Wilmer | C. Liddle | L. Langouche | J. Wauters | D. Mesotten | S. Coulter | S. Vander Perre | S. V. Perre | Yoo-Mee Vanwijngaerden | S. Vanderborght | Yoo‐Mee Vanwijngaerden | Sally Coulter
[1] K. Lindor. Farnesoid X receptor agonists for primary biliary cirrhosis , 2011, Current opinion in gastroenterology.
[2] R. Evans,et al. Extrahepatic Cancer Suppresses Nuclear Receptor–Regulated Drug Metabolism , 2011, Clinical Cancer Research.
[3] A. Peterson,et al. FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways , 2011, PloS one.
[4] M. Trauner,et al. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. , 2010, Pharmacology & therapeutics.
[5] J. Chiang,et al. Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.
[6] Wen Xie,et al. PXR and CAR in energy metabolism , 2009, Trends in Endocrinology & Metabolism.
[7] G. Van den Berghe,et al. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. , 2009, The Journal of clinical endocrinology and metabolism.
[8] Y. Wan,et al. 69 MECHANISMS OF RESISTANCE OF HEPATOCYTE RETINOID X RECEPTOR ALPHA-NULL MICE TO WY-14,643-INDUCED HEPATOCYTE PROLIFERATION AND CHOLESTASIS , 2009 .
[9] Johan Auwerx,et al. Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.
[10] G. Van den Berghe,et al. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients* , 2008, Critical care medicine.
[11] P. Metnitz,et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients—A prospective multicenter study , 2007, Critical care medicine.
[12] V. Bansal,et al. Jaundice in the intensive care unit. , 2006, The Surgical clinics of North America.
[13] M. Trauner,et al. Mechanisms of Disease: mechanisms and clinical implications of cholestasis in sepsis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.
[14] M. Trauner,et al. Molecular mechanisms of cholestasis , 2006, Wiener Medizinische Wochenschrift.
[15] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[16] T. Fiore,et al. Jaundice in critical illness: promoting factors of a concealed reality , 2006, Intensive Care Medicine.
[17] Ilse Vanhorebeek,et al. Intensive insulin therapy protects the endothelium of critically ill patients. , 2005, The Journal of clinical investigation.
[18] S. Poloyac,et al. Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice , 2005, Hepatology.
[19] R. Evans,et al. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Karpen,et al. Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: A novel mechanism for reduced hepatic gene expression in inflammation , 2004, Nuclear receptor.
[21] Ning Li,et al. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[22] C. Liddle,et al. Feed-forward Regulation of Bile Acid Detoxification by CYP3A4 , 2004, Journal of Biological Chemistry.
[23] K. Zatloukal,et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.
[24] D. Moore,et al. Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR , 2002, Science.
[25] J. Boyer,et al. Cellular localization and up‐regulation of multidrug resistance–associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver , 2001, Hepatology.
[26] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.
[27] G. Hooiveld,et al. Upregulation of the multidrug resistance genes mrp1 and mdr1b and downregulation of the organic anion transporter mrp2 and bile salt transporter spgp in endotoxemic rat liver , 1998 .
[28] P. Meier,et al. The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.
[29] D. Keppler,et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. , 1997, Gastroenterology.
[30] H. O. Wheeler,et al. The relationship between taurocholate secretion rate and bile production in the unanesthetized dog during cholinergic blockade and during secretin administration. , 1962, The Journal of clinical investigation.
[31] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.
[32] A. Burns,et al. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. , 2006, The Journal of biological chemistry.
[33] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.